AI-First Primary Care
A unified consultation platform for faster, safer triage with smart inbox tools and automated workflows
Software · Cloud SaaSCompany source
Company profile
About Huma
Huma operates the Huma Cloud Platform (HCP), a comprehensive infrastructure for building and deploying regulated AI and digital health solutions at scale. The platform serves as a governed model of reality that unifies clinical, operational, and research data, enabling teams to rapidly ship mission-critical software, orchestrate workflows, and automate decisions safely across care and life sciences. Huma's architecture consists of three layers: core infrastructure that connects disjointed digital health systems into a single federated network, a product layer with regulated applications for patient-flow, remote patient monitoring, and clinical dashboards, and an intelligence layer featuring analytics, AI agents, and machine learning tools that turn connected data into action. The company's flagship products include Huma Workspace, a low-code platform for building regulated medical applications, and Huma Intelligence, which provides clinical-grade AI capabilities including the Huma Intelligence Scribe for AI-powered transcription of clinical consultations. Huma also offers consumer-facing solutions like myGP, the UK's leading medical app for everyday healthcare access. The platform is deployed globally across 70+ countries, supporting approximately 100 million patients and powering over 100 applications for pharma companies, healthcare providers, and governments. All solutions are built to meet international regulatory standards including FDA 510(k) Class II, EU MDR Class IIb, and multiple other global certifications.
Company description Huma official website
Primary marketRemote Patient Monitoring & Wearables
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Huma?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Asthma
- COPD
- Diabetes
- Hypertension
- Knee surgery
- Myasthenia Gravis
- Oncology
Who it serves
- Government
- Health Systems
- Payers
- Pharma
- Providers
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
Markets70+ countries globally · Australia · Canada · European Union · India · Japan · Saudi Arabia · UAE · United Kingdom · United States
Company sourceOfficial website
Company milestones
Platform expansion
Launched Huma Intelligence Scribe built on NVIDIA for AI-powered transcription of clinical consultations, deployed at scale across the United States. Platform now supports 100+ applications and ~100M patients globally.
Partnerships
Recorded partners
- NVIDIA
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Huma Cloud Platform (HCP)
Federated infrastructure unifying clinical, operational, and research data for mission-critical software
Platform · Cloud SaaSCompany source
Huma Intelligence (Hi)
Clinical grade intelligence bringing analytics, AI agents, and ML tools that turn connected data into action
Platform · Cloud SaaSCompany source
Huma Intelligence Scribe
AI-powered transcription turning clinical consultations into structured, usable data
Software · Cloud SaaSCompany source
Huma myGP
The UK's #1 medical app for everyday healthcare access
Software · Cloud SaaSCompany source
Huma Workspace
Build regulated AI health apps faster, safer and with less effort using low-code tools
Platform · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Rebalancing α-Synuclein Clearance: Novel Therapeutic Frontiers in Parkinson's Disease.Neuromolecular medicine · Aug 31, 2026
Understanding the impact of Schwartz Rounds on healthcare workers.CJEM · Aug 10, 2026
Eudragit S100-coated microbeads of thiolated chitosan/casein for pH-responsive colon-targeted delivery of 6-mercaptopurine.RSC advances · Aug 5, 2026
Formulation development and preliminary biological evaluation of a menthol modified thermoresponsive tamoxifen sol-gel.Medical oncology (Northwood, London, England) · Jul 17, 2026
Effects of BAP and zinc nanoparticles on in vitro growth and antioxidant activity of Solanum tuberosum L.Scientific reports · Jun 27, 2026
Prognostic Significance of Inflammatory Biomarkers in First-Line Immunotherapy for Metastatic Melanoma: Multicentric Study.Cancers · May 25, 2026
Clinical validation
Clinical-trial records
Capturing Key MG-symptoms Using Smartphone Recordings.NCT06743490 · Sponsor · RECRUITING
Effect of a Structured Educational Intervention Through Mobile App on Hemoglobin A1c (HbA1c), Self-Efficacy and Self- Care in Adolescent With Type 1 Diabetes (T1DM)NCT07689318 · Mentioned · NOT YET RECRUITING
Pilot Testing Into the Feasibility of the Developed Cognitive Behavioral Therapy InterventionNCT07235852 · Mentioned · COMPLETED
Video Education With Result Dependent dIsclosureNCT05225428 · Mentioned · RECRUITING
Telerehabilitation Versus Supervised Pelvic Floor Muscle Training in Urinary IncontinenceNCT07151170 · Mentioned · ACTIVE NOT RECRUITING
Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple MyelomaNCT06182774 · Mentioned · RECRUITING
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
100+ applications built
Applications built and configured on HCP
~100M patients supported
Patients supported globally with HCP products
100+ global clients
Clients across pharma, providers, and governments
70+ countries
Platform deployed across 70+ countries
Global deployment across 70+ countries
Building AI-driven healthcare software at scale with trusted, regulated AI
Enabled organisations to build AI-driven healthcare software across 70+ countries
United States healthcare deployment
Deploying AI-powered clinical transcription at scale
Huma Intelligence Scribe deployed at scale across the United States
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Huma
Recent articles published on Huma's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
Lab-Grown Blood Vessels Show Promise in Reversing Heart Disease Damage
Preclinical studies reveal engineered vascular organoids can integrate with damaged heart tissue and restore blood flow, offering a regenerative alternative to traditional bypass surgery.
Clinical AI · Jul 3, 2026
Cancer's Escape Route: How Tumors Outsmart Billion-Dollar Blood Vessel Drugs
KAIST researchers reveal the molecular mechanism behind anti-VEGF therapy resistance, pointing toward AI-driven combination treatments that could finally stop cancer's vascular hijacking.
Clinical AI · Jul 3, 2026
AI-Powered Synthetic Heart Could End Animal Testing in Cardiac Device Development
Australian researchers have developed a soft robotic heart that uses artificial intelligence to replicate both healthy and diseased cardiac conditions, offering a breakthrough alternative for medical device testing.
Clinical AI · Jul 3, 2026
Robot Pharmacists Are Here: How AI-Powered Dispensing Could Solve Healthcare's Medication Error Crisis
Startup Queue emerges from stealth with autonomous pharmacy technology that eliminates human handling of medications while addressing critical workforce shortages.
Healthcare Operations · Jul 3, 2026
Million-Heart Dataset Deal Positions Australian Startup at Forefront of AI Cardiac Diagnostics Race
EchoIQ's exclusive access to up to one million echocardiogram scans represents one of the largest cardiovascular imaging datasets secured for AI development in the Asia-Pacific region.
Clinical AI · Jul 3, 2026
The Circadian Surgery Revolution: Why Your Heart Operation Time Might Matter as Much as Your Surgeon
Afternoon cardiac surgeries show significantly less heart muscle damage than morning procedures, as researchers discover our internal biological clocks may influence how patients respond to operations.
Clinical AI · Jul 2, 2026
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Remote Patient Monitoring & Wearables
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.